Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men

Research output: Contribution to journalArticlepeer-review

55 Scopus citations


Our investigations indicate that most patients with moderate hypertriglyceridemia have marked defects in metabolism of low-density lipoprotein (LDL) apolipoprotein B. Moreover, these patients have 2 major defects in the metabolism of triglyceride-rich lipoproteins, i.e., an accumulation of remnant lipoproteins (due in part to delayed hepatic clearance) and increased fractional conversion of very-low-density lipoprotein (VLDL) to LDL. Defective triglyceride-rich lipoprotein metabolism has been associated with insulin resistance. Statin therapy in hypertriglyceridemic patients improves the lipoprotein profile by decreasing both LDL cholesterol and remnant lipoproteins. However, statin therapy does not normalize LDL apolipoprotein B metabolism, and high-density lipoprotein (HDL) cholesterol levels remain low. Therefore, consideration may be given to combining a statin with a drug that alters triglyceride metabolism (e.g., fibrate or nicotinic acid) in high-risk patients with hypertriglyceridemia.

Original languageEnglish (US)
Pages (from-to)36B-42B
JournalAmerican Journal of Cardiology
Issue number4 A
StatePublished - Feb 26 1998

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men'. Together they form a unique fingerprint.

Cite this